How Companies Are Trading Innovation Quality for Quantity - Ideas for Leaders
Idea #512

How Companies Are Trading Innovation Quality for Quantity

This is one of our free-to-access content pieces. To gain access to all Ideas for Leaders content please Log In Here or if you are not already a Subscriber then Subscribe Here.
Main Image
Main Image


When it comes to innovation, are companies mistaking quantity for quality? New research shows that companies who file for a greater number of patents are also filing for patents that are less valuable. This leads to overestimating one’s research productivity — and undermining future innovation.


How successful are your innovation efforts? For many companies, proof of groundbreaking innovation comes in the form of patents. The question about research productivity is often answered by how many inventions have emerged from a company’s R&D capabilities, as measured by the number of patents filed.

Quantity, however, does not necessarily mean quality. The true measurement of a company research capability has to include both quantity and quality. More patents of lesser value each is not necessarily more productive than less patents of greater value each. And it is possible that there is a trade-off: companies are going for quick wins with patents of lesser value instead of putting in the time, effort and money to make important research breakthroughs.

The first challenge in determining whether such a trade-off is occurring — whether companies are sacrificing patent quality for quantity — is to measure patent quality. One measure might be the number of citations: the more the research is cited by patent examiners, the greater the value. Another might be renewals of the patent: the more valuable patents are more likely to be renewed for a longer period of time.

Internationally, however, these measures are hard to conciliate since there is an enormous diversity of rules, regulations and practices (for example, citation practices) among different countries.

The most effective measure of patent value is ‘family size’ — which refers to the average number of countries in which patent protection was sought. Research has shown that family size (after controlling for variables such as size of firm and whether the firm is part of a larger group) is directly correlated with both technological and economic value.

The second challenge is to account for a firm’s ‘propensity to patent’. Some companies want to patent everything, often as a defensive measure against competitors. Other companies focus on a small number of priority patents. A greater propensity to patent is going to automatically lower the average quality of patents — there are more patents to bring the curve down. In contrast, a company that focuses only on a very few key patents will boast a higher ‘average’ quality.

In 2013, using survey data from the European Patent Office covering nearly 800 companies that had filed patents with the EPO in 2005, professor Gaétan de Rassenfosse from the University of Melbourne (he has since moved to the Ecole polytechnique fédérale de Lausanne in Switzerland) conducted an econometric analysis comparing patent value to number of patents. The result of his analysis confirms that — controlling for all other variable factors among the firms, including the propensity to patent — a greater number of patents was equated with lower quality. The more a company invented, the less valuable its inventions. 


The results of the study have important implications for managers. The first and most obvious is for managers to rethink their measures of innovation or research productivity. Rather than relying on quantity, the quality of inventions must also be taken into account when assessing productivity, despite the difficulty of measuring quality.

The existence of a trade-off also means that managers should be very cautious about setting quantity targets and thereby unwittingly undermining the quality of their research. At stake is not simply the short-term issue of research productivity. The invention process builds on previous inventions, which means that as quality is reduced, the company is laying less groundwork for future high-quality inventions. In short, impressive numbers of patents may in fact be undermining the future innovation capabilities of the firm.



Do Firms Face a Trade-Off between the Quantity and the Quality of Their Inventions? Gaétan de Rassenfosse. Research Policy (June 2013).

Ideas for Leaders is a free-to-access site. If you enjoy our content and find it valuable, please consider subscribing to our Developing Leaders Quarterly publication, this presents academic, business and consultant perspectives on leadership issues in a beautifully produced, small volume delivered to your desk four times a year.



Idea conceived

February 1, 2013

Idea posted

May 2015
challenge block
Can't find the Idea you are after?
Then 'Challenge Us' to source it.


For the less than the price of a coffee a week you can read over 650 summaries of research that cost universities over $1 billion to produce.

Use our Ideas to:

  • Catalyse conversations with mentors, mentees, peers and colleagues.
  • Keep program participants engaged with leadership thinking when they return to their workplace.
  • Create a common language amongst your colleagues on leadership and management practice
  • Keep up-to-date with the latest thought-leadership from the world’s leading business schools.
  • Drill-down on the original research or even contact the researchers directly

Speak to us on how else you can leverage this content to benefit your organization.